Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

Radner, H; el-Shabrawi, Y; Eibl, RH; Brüstle, O; Kenner, L; Kleihues, P; Wiestler, OD.
Tumor induction by ras and myc oncogenes in fetal and neonatal brain: modulating effects of developmental stage and retroviral dose.
ACTA NEUROPATHOL. 1993; 86(5): 456-465. Doi: 10.1007/BF00228580
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
El-Shabrawi Yosuf
Kenner Lukas
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Introduction into fetal rat brain cells of a replication-defective retroviral vector harboring v-Ha-ras and v-gag-myc rapidly causes the induction of highly malignant undifferentiated neuroectodermal tumors following transplantation into the brains of syngeneic hosts [Wiestler, et al. (1992) Cancer Res. 52: 3760-3767]. In the present study, we have investigated the modulating effect of the developmental stage of neural target cells and of the dose of the retroviral vector used in the grafting experiments. Exposure of fetal cells from embryonic day (E)12 or E14 produced a 100% incidence of malignant neuroectodermal tumors which led to the death of recipient animals after a median latency period of 32 days. A 100-fold reduction of the virus dose from 2.062 x 10(6) to 2.062 x 10(4) focus-forming units/ml resulted in a lower tumor incidence of 25%. Of six neural grafts exposed to v-Ha-ras and v-myc at E16, only one showed evidence of tumorigenesis (low-grade astrocytoma and hemangioma). All other transplants were morphologically normal for observation periods of 26 weeks, indicating a marked loss of transforming activity of ras and myc in more advanced stages of brain development. In retrovirus-exposed donor cells which caused the development of neural tumors in recipient rats, malignant transformation was also evident during culture in vitro, usually after 9-12 days. Oncogene complementation was also studied in the newborn rat brain. After microinjection of the retroviral vector into the brain at postnatal day (P)0, P1 and P3, 5 out of 20 animals (25%) developed a total of seven brain tumors. Histopathologically, three of these neoplasms were malignant neuroectodermal tumors which, in contrast to those induced in fetal brain transplants showed evidence of focal glial and/or neuronal differentiation. In addition, we observed one oligodendroglioma, two hemangiomas and a malignant hemangioendothelioma. These data indicate that neural precursor cells and endothelia of the rat brain represent the major target cells for the complementary action of ras and myc and that the use of target cells from later developmental stages (E16 and postnatal) leads to the induction of both primitive and more differentiated neoplasms.
Find related publications in this database (using NLM MeSH Indexing)
Animals -
Animals, Newborn - genetics
Brain Neoplasms - embryology
Female - embryology
Gene Expression Regulation, Neoplastic - embryology
Genes, myc - embryology
Genes, ras - embryology
Leukemia, Experimental - embryology
Male - embryology
Moloney murine leukemia virus - genetics
Neoplasm Transplantation - genetics
Pregnancy - genetics
Rats - genetics
Rats, Inbred F344 - genetics
Retroviridae Infections - embryology
Tumor Cells, Cultured - embryology
Tumor Virus Infections - embryology

Find related publications in this database (Keywords)
Retroviral Vectors
Oncogene
Ras
Myc
Grafting
Brain Tumors
© Med Uni GrazImprint